Health & Nutrition

bg
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai

European drug regulator rejects Alzheimer's treatment Leqembi...

The committee said Leqembi's effect on delaying cognitive decline does not outweigh...

bg
Dexcom shares plummet almost 40% after company misses on revenue, lowers guidance

Dexcom shares plummet almost 40% after company misses on...

Dexcom issued disappointing results and guidance, which the company attributed in...

bg
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs 

Bristol Myers Squibb beats earnings estimates, raises outlook...

The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and...

bg
GE HealthCare taps Amazon Web Services to build generative AI for medical use

GE HealthCare taps Amazon Web Services to build generative...

GE HealthCare and AWS team up to build generative AI applications for medical use

bg
India is on alert after a fresh outbreak of the deadly Nipah virus. Here’s what you need to know

India is on alert after a fresh outbreak of the deadly...

Health authorities in the southern Indian state of Kerala are on high alert for...

bg
Viking Therapeutics stock jumps 30% after drugmaker moves weight loss injection to late-stage trial

Viking Therapeutics stock jumps 30% after drugmaker moves...

It brings the drugmaker one step closer to joining the market for GLP-1s, which...

bg
Corporate Influence and Our Epidemic of Obesity 

Corporate Influence and Our Epidemic of Obesity 

Like the tobacco industry adding extra nicotine to cigarettes, the food industry...

bg
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment

Novo Nordisk's Wegovy weight loss drug wins UK approval...

The U.K.'s health regulator on Tuesday approved the use of Novo Nordisk's Wegovy...

bg
Pfizer's gene therapy for rare genetic bleeding disorder succeeds in late-stage trial

Pfizer's gene therapy for rare genetic bleeding disorder...

The hemophilia A treatment could become the company's second gene therapy to enter...

bg
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end

Healthy Returns: The first round of Medicare drug price...

The first round of Biden's Medicare drug price negotiations is nearly finished....